ResearcherInstitut d'Investigació Biomédica de BellvitgeActive in the last 2 years

Luis Secanella

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5157973531. Sources: ClinicalTrials.gov.

Their work

Papers: 1
Trials: 1 (principal investigator on 1)
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2022: 1 trial · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 1

Technical options in the occlusion of the superior mesenteric vein for locally advanced pancreatic cancer. Co-author DOI 10.1016/j.cireng.2026.800395 ↗

Trials 1

Predictive Factors for Resection and Survival in Type A Borderline Resectable Pancreatic Ductal Adenocarcinoma Patients After Neoadjuvant Therapy Principal investigator NCT05489458 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Elena Iborra Ortega · 1 shared paper, 2026 · strength 0.39
- Paper Technical options in the occlusion of the superior mesenteric vein for locally advanced pancreatic cancer. DOI 10.1016/j.cireng.2026.800395 ↗
Juli Busquets · 1 shared paper, 2026 · strength 0.39
- Paper Technical options in the occlusion of the superior mesenteric vein for locally advanced pancreatic cancer. DOI 10.1016/j.cireng.2026.800395 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.